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Summary. A basic problem in genetic counseling of 
families with Duchenne/Becker muscular dystrophy 
(DMD/BMD) concerns the carrier status of female rela- 
tives of an affected male. In about 60% of these patients, 
deletions of one or more exons of the dystrophin gene 
can be identified. These deletions preferentially include 
exon 45, which can be detected by multiplex polymerase 
chain reaction (PCR) and Southern blot analysis of ge- 
nomic cosmid clones that map to this critical region. As 
a new approach for definitive carrier detection, we have 
performed chromosomal in situ suppression (CISS) hy- 
bridization with these cosmid clones in female relatives 
of four unrelated patients. In normal females, most meta- 
phases howed signals on both X chromosomes, whereas 
only one X chromosome was labeled in carriers. Our re- 
suits demonstrate hat CISS hybridization can define the 
carrier status in female relatives of DMD patients exhib- 
iting a deletion in the dystrophin gene. 
Introduction 
The gene responsible for Duchenne/Becker muscular dys- 
trophy (DMD/BMD) maps to Xp21 and is the largest 
human gene known so far. At least 65 exons coding for 
an mRNA of 14kb are distributed within a region of 
2.3 Mb (for review see Love and Davies 1989). Recently, 
the coded protein, called dystrophin, has been identified. 
It is localized at the cytoplasmic face of the plasma mem- 
brane of the muscle fibers. In DMD patients, no dystro- 
phin can be detected in muscle tissue using antibodies 
against defined regions of dystrophin (Hoffman et al. 
1987; Koenig et al. 1988; Bonilla et al. 1988), whereas 
BMD patients usually show an altered molecular weight 
of dystrophin (Arahata et al. 1989). 
Within the dystrophin gene deletions that lead to the 
disease phenotype can be detected in about 60% of DMD 
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patients (Koenig et al. 1989; Den Dunnen et al. 1989). 
Approximately 60% of these deletions include exon 45 
and occur in the region defined by the probe P20 (Wape- 
naar et al. 1988). 
About one third of all DMD patients arise by new 
mutations. In the remainder, the mutation has occurred 
in one of the germ cells that formed the zygote in an ear- 
lier generation. This situation results in a high carrier 
risk for the mother and other female relatives of an af- 
fected boy (Davie and Emery 1978). 
In addition to clinical investigations (for review see 
Moser 1984), there are several biochemical and molec- 
ular approaches for carrier detection. All these approaches 
have their limitations (see Discussion). We have devel- 
oped a direct approach that enables us to define un- 
equivocally the carrier status of female relatives from pa- 
tients exhibiting a deletion. This approach is based on 
the site-specific hybridization of cosmid clones using chro- 
mosomal in situ suppression (CISS) hybridization (Lan- 
degent et al. 1987; Lichter et al. 1990; Kievits et al. 1990). 
Here, we used three cosmid clones spanning the region 
around exon 45 (Fig. 1). Using a clone containing a 
DNA region that is deleted in the patient, carriers are 
expected to show a signal in Xp21 only on one of their X 
chromosomes, whereas in non-carriers both of the X chro- 
mosomes hould exhibit a hybridization signal. 
Families and methods 
Families 
Four possible carriers (probands) of the dystrophin gene were in- 
vestigated in four independent families A, B, C and D (Fig. 2). In
each of these families, the diagnosis of DMD or BMD was con- 
firmed by the presence of a DMD-cDNA deletion detected by a 
multiplex PCR analysis in the affected boys. In family A, the pa- 
tient (A3) expressed a dystrophin of reduced molecular weight 
supporting the diagnosis of BMD, in agreement with a mild clinical 
course of the disease. Dystrophin was absent in the patient (C3) of 
family C, indicating DMD. D4 is a BMD patient with a dystrophin 
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Fig. 1. Localization of cosmid clones cPT1, 
cAL24 and cPT4 in the P 20 subregion of the 
DMD gene (for further details see Blonden et al. 
1989) 
of reduced weight and abundance. In the patient (B8) of family B, 
dystrophin was not investigated. In this family, DMD was evident 
by the clinical course and pedigree analysis. Three healthy non-re- 
lated women not carrying a detectable dystrophin gene deletion 
and an obligate carrier of family B (B4, as indicated by pedigree 
analysis) served as controls. 
Methods 
Multiplex PCR-analysis. The nine primer pairs described by 
Chamberlain et al. (1989) and an additional primer pair (Speer et 
al. 1989) were used for amplification of 200 ng of template DNA 
according to the protocol of Chamberlain etal. (1989) with the fol- 
lowing modifications: 25 cycles using 2.5 units CETUS Taq-poly- 
merase were performed and no DMSO was added. Amplification 
products were s parated on a 3% NuSieve agarose gel (Seakem) in 
1 x TBE buffer. 
DNA-Probes. DNA from the three cosmid clones cPT1, cAL24, 
cPT4 (Blonden et al. 1989, see also Fig. 1) and from the plasmid 
pXBR containing human X centromer-specific alphoid repeat (Yang 
et al. 1982) were prepared according to standard procedures (Mani- 
atis et al. 1982). Probes were labeled by nick-translation substitut- 
ing dTI'P by Biotin-11-dUTP (Sigma) as described by Langer et al. 
(1981). A phage DNA library established from sorted human X 
chromosomes was purchased from ATTC (catalog no.: 57750) and 
labeled by nick-translation with Digoxigenin-11-dUTP (Boehringer 
Mannheim, FRG). 
Cosmid hybridization of Southern-blots. Digestion of human geno- 
mic DNA with HindlII, gel electrophoresis and Southern blotting 
were performed following standard procedures. Labeling of cos- 
mid probe DNA with random priming and competitive hybridiza- 
tion were carried out as described (Blonden et al. 1989). 
Chromosome preparation and CISS-hybridization. Metaphase 
spreads from PHA-stimulated human lymphocytes were fixed with 
acetic acid/methanol (1:3 v/v) and stored until use at -80~ 
CfSS-hybridization f biotinylated cosmid clones was carried out 
as described by Lichter et al. (1990). In experiments u ing a single 
cosmid clone, 200 ng labeled cosmid DNA, 2 lag sonicated human 
placenta DNA for competition and 8 lag sonicated salmon sperm 
DNA (Sigma) were added to 10 lal hybridization mixture (suffi- 
cient for an area of 18 x 18mm) containing 50% formamide 
(Fluka), 10% dextran sulfate and 1 x SSC. In other experiments, 
all three cosmid clones were combined using 100 ng of each labeled 
probe. When co-hybridization with pXBR was performed, 20 ng 
probe DNA in 1 lal hybridization mixture were added to the cosmid 
probe after the preannealing step (Cremer et al. 1988). Hybridized 
probes were detected with fluorescein-conjugated avidin (Vector 
Laboratories). The signal was amplified once using a biotinylated 
anti-avidin antibody (Vector Laboratories) and subsequent detec- 
tion with fluorescein-conjugated avidin (Pinkel et al. 1986). For 
co-hybridization f the whole X-library, 400 ng digoxogenin-label- 
ed total phage DNA from this library and 100 ng of each biotiny- 
lated cosmid was used. The signals were detected with a TRITC- 
conjugated anti-digoxigenin a tibody (Boehringer Mannheim) and 
the subsequent detection of the cosmid clones using avidin-conju- 
gated to FITC and one amplification step (see above). Fluores- 
Famity A Family C 
? ,% ?, 
Fatuity B Family 0 
Fig. 2. Pedigrees of families A, B, C and D 
Fig. 3a, b. Multiplex DNA amplification of genomic DNA from 
patients A3, B8 and C3. Amplification products in a represent 
exons 45 (547 bp-band), 19 (459 bp), 51 (409 bp), 8 (360 bp) and 
44 (268 bp) of the dystrophin gene, and in b represent exons 48 
(506 bp), 17 (416 bp), 51 (388 bp), 12 (331 bp) and 4 (196 bp). Pa- 
tient A3 presents a deletion of the dystrophin gene from exon 45 to 
at least exon 52, patient B8 from exon 45 to 51 and patient C3 only 
for exon 45. As a control, DNA from a normal male was amplified. 
We used a 123-bp ladder (M) as size marker 
cence microscopy was performed with a Zeiss Photomikroskop III
equipped for epifluorescence. Photographs were taken on an Ag- 
fachrome 1000 RS color slide film. 
Results 
The DNA of pat ients A3,  B8 and C3 (Fig. 2), screened 
for a delet ion using the mult iplex PCR-pr imer  system 
(Fig. 3), shows the loss of exon 45 of the dystrophin 
gene. To determine whether  the delet ion around exon 
45 extends at least the length of the cosmid cPT1 (Fig. 1), 
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library labeled with digoxigenin for rapid identification 
of the X chromosomes and the biotinylated cPT1 cosmid 
clone. D2 showed hybridization sig als with cPT1 on both 
X chromosomes on metaphase preads (Fig. 5c,d); Tab- 
le 1) and in nuclei (Fig. 5e, f), suggesting that she does 
not carry the DMD mutation (for the possibility of germ- 
line mosaicism, see Discussion). Proband D3 (Fig. 2), 
however, referred to us for genetic ounseling, could de- 
finitely be excluded as a carrier for this mutation (see 
Discussion). 
Fig. 4. Southern-blot hybridization f HindIII-digested DNA of 
DMD/BMD patients with the cosmid clones cPT1, cAL24 and 
cPT4. The normal control shows the expected bands. Patients A3 
and C3 are deleted for all three cosmids, whereas patient B8 is 
completely deleted for cPT1 and partially for cAL24 and cPT4 
Southern blots from these patients were hybridized with 
the cosmids cPT1, cAL24 and cPT4 (Fig. 4). In patients 
A3 and C3, all three cosmid clones were deleted. In pa- 
tient B8, only cPT1 was completely deleted, whereas the 
two other clones were partially deleted (Fig. 4). Based 
on these results, CISS-hybridization f metaphase preads 
from the obligate carrier B4 and the possible carrier B3 
were performed with the cPT1 clone, whereas the possi- 
ble carriers A2 and C2 in the other two families were in- 
vestigated by CISS-hybridization with either cPT1 or the 
pooled clones cPT1, cAL24 and cPT4, in order to im- 
prove the hybridization signal. 
CISS-hybridization of the single or pooled cosmid 
clones to metaphase spreads from healthy non-related 
female individuals from three non-affected families re- 
sulted in specific signals on both X chromosomes in most 
metaphase preads (Fig. 5a, Table 1). 
As expected, inthe obligate carrier B4, only on X chro- 
mosome was labeled by cPT1 in all metaphase spreads 
that exhibited specific signals with this probe. There was 
no case of a metaphase pread exhibiting label on both X 
chromosomes (Fig. 5b, Table 1). The co-hybridization f 
the repetitive centromere probe pXBR (Yang et al. 1982) 
was used to facilitate the identification of the deleted X
chromosome (Fig. 5b). The same result was seen in her 
sister B3 (with a 50% a priori risk of being a carrier) and 
demonstrates unequivocally that she carries the same de- 
letion (Table 1). This result hus enables the direct inves- 
tigation of the carrier status of the daughters ofB3 by the 
method of CISS hybridization. Moreover, CISS-hybri- 
dization with the pooled cosmids performed in the pro- 
bands A2 and C2 also resulted in the specific labeling of 
one X chromosome only, establishing that both probands 
are carriers of the deleted X chromosome (Table 1). 
After the investigation f the described three families 
had been completed, family D was included in this study. 
Patient D4 showed a deletion of exons 45-48 by PCR 
reaction and a complete deletion of the cPT1 clone in 
Southern blot hybridization (data not shown). Using 
samples from his mother D2, a possible carrier, we per- 
formed cohybridization with an X-chromosome-specific 
Discussion 
Because of the high proportion of new mutations, which 
are estimated to be about 30% in DMD/BMD patients, 
genetic ounseling of female relatives provides aparticu- 
lar problem when the carrier status cannot be deduced 
by pedigree analysis alone. The usefulness of the present 
biochemical nd molecular approaches of carrier detec- 
tion is limited. An elevation of the level of creatine 
kinase (CK) in carriers was first described by Schapira et 
al. (1960). However, since only 70% of adult carriers 
have an elevated CK level, a normal CK value does not 
exclude carrierships (Moser 1984). Intragenic restriction 
fragment length polymorphisms (RFLPs) to identify the 
X chromosome s gregating with the DMD mutation may 
be misleading because of possible recombinations be- 
tween the site of a DNA marker and the mutation site 
(Bakker et al. 1986). In sporadic ases, the carriership of 
the mother as studied by RFLP analysis may be consid- 
ered unlikely if a second healthy son carries the same X 
chromosome ashis affected brother. Such an interpreta- 
tion, however, may also be misleading because of the pos- 
sibility of germline mosaicism (Bakker et al. 1989; Dar- 
ras et al. 1988). In cases with a defined deletion, gene 
dosis analysis in Southern blots from maternal DNA pro- 
vides a further possibility for carrier detection (Mao and 
Cremer 1989). Under routine laboratory conditions, how- 
ever, it may be problematic to base the decision of the 
carrier status of a female relative solely on this type of 
analysis. A definite carrier diagnosis can also be achiev- 
ed by the identification of size altered fragments detect- 
ed by field inversion gel electrophoresis (FIGE), but may 
not yield unequivocal results if the deletions are small 
(Chen et al. 1988). In DMD families, immunostaining of 
muscle tissue by dystrophin antibodies has been success- 
fully used only for the detection of carriers with elevated 
CK levels. In BMD families, the usefulness of immuno- 
staining or immunoblotting for carrier detection has not 
been established so far (Arahata et al. 1989; Miranda et 
al. 1989). 
In this study, we have demonstrated that CISS-hy- 
bridization of cosmid probes specific for a deleted sub- 
region of a patient's dystrophin-gene can be used to in- 
vestigate directly the presence of this subregion on one 
or both X chromosomes of female relatives. In cases 
where only one X chromosome shows a hybridization 
signal, this approach provides unequivocal evidence con- 
firming the carrier status of these females, even if the 
CK or RFLP analysis is not informative. 
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Fig. 5a-f. CISS hybridization of DMD- 
specific cosmid clones, a Metaphase 
spread of a normal female hybridized 
with the biotinylated cosmid cPT1 and 
counterstained with propidium iodide. 
On both X chromosomes, fluorescence 
signals are seen on both chromatids of the 
short arm. x2000, b Metaphase spread of 
an obligate carrier of family B (B4) after 
co-hybridization ofthe centromere-specific 
probe pXBR and cPT1. Chromosomes 
are counterstained with propidium 
iodide. The centromeres ofboth X 
chromosomes are delineated with pXBR 
(arrowheads). The cosmid signals on 
Xp are seen on one X chromosome 
(arrows) but not on the other, x 1500. 
c, d Metaphase spread of a possible carrier 
D1 after double hybridization with an 
X-chromosome-specific l brary and cPT1. 
Both X chromosomes are delineated 
using a filter for rhodamine fluorescence 
(c). The cosmid signal is clearly seen on 
both X chromosomes with a filter for 
fluorescein. Even with this filter, the X 
chromosomes can be detected ( ). 
• 2000. e, f Hybridization signal on a 
prophase nuclei of the same patient. 
Rhodamine filter (e) and fluorescein filter 
(f). x 1400 
In cases where both X chromosomes contained in the 
somatic cells of a female relative show hybridization sig- 
nals, the interpretation is more complicated because of 
the repeated observation of germline mosaicisms in the 
mother  (Bakker et al. 1989; Darras et al. 1988). Accord- 
ingly, such a finding does not rule out unequivocally a
recurrence risk for further pregnancies of the mother,  
and prenatal diagnosis should still be offered. For the 
same reason, sisters of  the patients may possibly be car- 
riers and should be investigated independently of the 
outcome in the mother. On the other hand, a normal re- 
suit in the somatic cells of a patient's mother  would be 
sufficient o rule out the possibility of a carriership in her 
sisters. 
Our  approach is limited by the fact that deletions in 
the dystrophin gene can be detected so far in only 60% 
of the patients. In the families presented in this investi- 
gation, a deletion spanned at least the length of one cos- 
mid clone, i.e., about 40 kb. The progress of non-radio- 
active in situ hybridization techniques has made it possi- 
ble to detect single-copy targets as small as 2-5  kb (Lich- 
ter et al. 1988; Cherif et al. 1989). Accordingly, all iden- 
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Table 1. Evaluation of hybridization efficiency with the DMD-spe- 
cific cosmid probes (only cPT1 or three cosmids as a pool). From 
each proband expect D1 (50), 100 metaphases were counted 
Proband Probe N Hybridization signal 
BothX OneX None 
A1 Pool 100 0 93 7 
B3 cPT1 100 0 94 6 
B4 cPTI 100 0 91 9 
C1 Pool 100 0 92 8 
D1 cPT1 50 43 1 6 
Normal Pool 100 85 2 13 
Females Pool 100 91 1 8 
cPT1 100 89 2 9 
tif iable delet ions more  than 2 kb in size in the dystrophin 
gene should be accessible to this technique prov ided that 
the necessary clones become avai lable for in situ hybrid-  
ization. In famil ies where the affected males have al- 
ready deceased,  in situ hybr id izat ion of probes defining 
de let ion-prone subregions of the dystrophin gene may 
be direct ly used to screen potent ia l  carriers. Such an ap- 
proach will become even more  powerfu l  fol lowing the 
deve lopment  of mult i  color in situ hybr id izat ion tech- 
niques that al low the s imultaneous taining of mult ip le 
gene targets in dif ferent colors (Neder lo f  et al. 1990). 
We expect that,  in addit ion to the analysis of X chromo- 
somes in metaphase spreads,  DMD carr ier detect ion will 
become possible in future by the analysis of mult ico lored 
hybr id izat ion signals directly in interphase nuclei. 
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